3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸
|
|
- CAS号:
- 161230-88-2
- 英文名:
- (Z)-2-CARBOXY-4,6-DICHLOROINDOLE-3-(2'-PHENYL-2'-CARBOXY)-ENE
- 英文别名:
- MDL-105212;MDL 105,519;MDL 105,519 >=98% (HPLC), solid;(Z)-2-CARBOXY-4,6-DICHLOROINDOLE-3-(2'-PHENYL-2'-CARBOXY)-ENE;3-[(1E)-2-Carboxy-2-phenylethenyl]-4,6-dichloro-1H-indole-2-carboxylic acid;1H-Indole-2-carboxylic acid, 3-[(1E)-2-carboxy-2-phenylethenyl]-4,6-dichloro-
- 中文名:
- 3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸
- 中文别名:
- 化合物 T16032;3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸
- CBNumber:
- CB8317737
- 分子式:
- C18H11Cl2NO4
- 分子量:
- 376.19
- MOL File:
- Mol file
|
|
|
3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸化学性质
-
沸点:
-
601.3±55.0 °C(Predicted)
-
|
-
密度:
-
1.594±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO: 5 mg/mL
-
|
-
酸度系数(pKa):
-
3.20±0.19(Predicted)
-
|
-
形态:
-
solid
-
|
-
颜色:
-
white
-
|
3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸性质、用途与生产工艺
MDL 105519是有效和选择性的甘氨酸与 NMDA 受体结合的拮抗剂。
MDL 105519 is a potent and selective ligand for the glycine recognition site that completely inhibit the binding of [
3
H]glycine to rat brain membranes with a K
i
value of 10.9 nM. MDL 105519 is approximately 10,000-fold selective for the glycine recognition site relative to the other receptor types investigated. MDL 105519 inhibits NMDA-dependent responses, such as elevations of [
3
H]TCP binding in brain membranes, cyclic GMP accumulation in brain slices, and alterations in cytosolic Ca
2+
and Na
+
-Ca
2+
currents in cultured neurons. Inhibition is non-competitive with respect to NMDA and could be nullified with D-serine.
MDL 105519 is an NMDA receptor antagonist
in vivo
. Intravenously administration of MDL 105519 prevents harmaline-stimulated increases in cerebellar cyclic GMP content, providing biochemical evidence of NMDA receptor antagonism
in vivo
. This antagonism is associated with anticonvulsant activity in genetically based, chemically induced, and electrically mediated seizure models. Anxiolytic activity is observed in the rat separation-induced vocalization model, but muscle-relaxant activity is apparent at lower doses. Higher doses impair rotorod performance, but are without effect on mesolimbic dopamine turnover or prepulse inhibition of the startle reflex.
3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/08/19 | HY-15085 | 3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸 MDL 105519 | 161230-88-2 | 5mg | 1000元 |
2024/08/19 | HY-15085 | 3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸 MDL 105519 | 161230-88-2 | 10mM * 1mLin DMSO | 1100元 |
3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸
生产厂家
161230-88-2, 3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸 相关搜索:
- C18H11Cl2NO4
- 化合物 T16032
- 3-[(1E)-2-羧基-2-苯乙烯基]-4,6-二氯-1H-吲哚-2-羧酸
- 161230-88-2
- 1H-Indole-2-carboxylic acid, 3-[(1E)-2-carboxy-2-phenylethenyl]-4,6-dichloro-
- MDL 105,519 >=98% (HPLC), solid
- (Z)-2-CARBOXY-4,6-DICHLOROINDOLE-3-(2'-PHENYL-2'-CARBOXY)-ENE
- 3-[(1E)-2-Carboxy-2-phenylethenyl]-4,6-dichloro-1H-indole-2-carboxylic acid
- MDL 105,519
- MDL-105212